Skip to content

Dose-Response of Exercise on Long-Term Weight Loss

Dose-Response of Exercise on Long-Term Weight Loss

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00177762
Enrollment
200
Registered
2005-09-15
Start date
1999-09-30
Completion date
2002-12-31
Last updated
2005-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Weight Loss

Brief summary

The purpose is to examine varying durations and intensities of exercise on long-term weight loss.

Interventions

BEHAVIORALbehavior weight loss

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

1. Female 2. 21-45 years of age 3. BMI = 27-40 kg/m2 4. Ability to provide informed consent. 5. Ability to provide consent from their personal physician to participate in this study.

Exclusion criteria

1. Reporting regular exercise participation of at least 20 minutes per day on at least 3 days per week during the previous six months. (This study is designed to recruit relatively sedentary adults.) 2. Diabetes, hypothyroidism, or other medical conditions which would affect energy metabolism. 3. Currently pregnant, pregnant within the previous six months, or planning on becoming pregnant within the next 24 months. (Pregnancy will be based on self-report and will be included on the detailed medical history that is completed by subjects.) 4. Non-medicated resting systolic blood pressure \>160 mmHg or non-medicated resting diastolic blood pressure \>100 mmHg, or taking medication that would affect blood pressure. 5. Taking medication that would affect resting heart rate or the heart rate response during exercise (e.g., beta blockade). 6. Arrhythmia on resting or exercise electrocardiogram that would indicate that vigorous exercise was contraindicated. 7. History of myocardial infarction or valvular disease. 8. History of orthopedic complications that would prevent optimal participation in the exercise component (e.g., heel spurs, severe arthritis).

Design outcomes

Primary

MeasureTime frame
weight loss

Secondary

MeasureTime frame
fitness
dietary intake
physical activity
mediators
body composition

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026